LENZ Therapeutics (LENZ) grants options and RSUs to commercial chief

Rhea-AI Filing Summary

LENZ Therapeutics’ Chief Commercial Officer, Shawn Olsson, reported new equity awards. On January 2, 2026, Olsson received a stock option covering 84,200 shares of LENZ Therapeutics common stock at an exercise price of $16 per share, expiring on January 1, 2036. The option vests over time, with 25% of the shares vesting on the one-year anniversary of January 2, 2026 and the remaining shares vesting monthly thereafter while Olsson continues as a service provider.

On the same date, Olsson was also granted 14,000 restricted stock units, each representing a right to receive one share of common stock. These RSUs vest with 25% of the award vesting on the one-year anniversary of the January 2, 2026 grant date, and the rest vesting in equal installments every six months, subject to continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Olsson Shawn

(Last) (First) (Middle)

C/O LENZ THERAPEUTICS, INC.

201 LOMAS SANTA FE, SUITE 300

(Street)

SOLANA BEACH CA 92075

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LENZ Therapeutics, Inc. [ LENZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$16	01/02/2026		A		84,200		(1)	01/01/2036	Common Stock	84,200	$0	84,200	D
Restricted Stock Unit	(2)	01/02/2026		A		14,000		(3)	(3)	Common Stock	14,000	$0	14,000	D

Explanation of Responses:

1. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean January 2, 2026.

2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the RSU Grant Date, and one eighth (1/8th) of the RSUs subject to the award shall vest every six (6) months thereafter on the same day of the month as the RSU Grant Date (and if there is no corresponding day, on the last day of the month). "RSU Grant Date" shall mean January 2, 2026.

Remarks:

	/s/ Daniel R. Chevallard, as Attorney-in-Fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LENZ (LENZ) report for Shawn Olsson?

The filing reports that Chief Commercial Officer Shawn Olsson received a stock option for 84,200 shares and 14,000 restricted stock units on January 2, 2026.

What are the terms of Shawn Olsson’s LENZ stock option grant?

Olsson’s stock option covers 84,200 shares of common stock at an exercise price of $16 per share, expiring on January 1, 2036, and vests over time based on continued service.

How do the LENZ restricted stock units granted to Shawn Olsson vest?

For the 14,000 RSUs, 25% vest on the one-year anniversary of the January 2, 2026 grant date, with the remaining RSUs vesting in equal installments every six months, subject to continued service.

Does each RSU granted to Shawn Olsson equal one share of LENZ common stock?

Yes. Each restricted stock unit (RSU) represents a contingent right to receive one share of LENZ Therapeutics common stock.

Is the equity awarded to Shawn Olsson directly owned according to the filing?

Yes. The filing shows the 84,200 stock options and 14,000 RSUs as direct (D) ownership by Shawn Olsson.

What continued service conditions apply to Shawn Olsson’s LENZ equity awards?

Both the stock option and RSU grants require Olsson to continue as a service provider under the 2024 Equity Incentive Plan through each applicable vesting date.